4.1 Article

European standard clinical practice-Key issues for the medical care of individuals with familial leukemia

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Hematology

Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN

Hartmut Doehner et al.

Summary: The 2010 and 2017 editions of the European LeukemiaNet recommendations for AML diagnosis and management are widely recognized. There have been major advances in our understanding of AML, including disease classification updates, improvements in genomic diagnostics, and the development of new therapeutic agents. This update includes a revised genetic risk classification, response criteria, and treatment recommendations.
Article Hematology

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

Daniel A. Arber et al.

Summary: In 2016, the WHO, Society for Hematopathology, and European Association for Haematopathology collaborated to update the classification of myeloid neoplasms and acute leukemias, advancing the field of myeloid neoplasms and acute leukemias.
Review Oncology

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

Joseph D. Khoury et al.

Summary: This paper summarizes the new WHO classification scheme for myeloid and histiocytic/dendritic neoplasms, emphasizing the refinement of diagnostic criteria and the importance of actionable biomarkers, while maintaining global applicability.

LEUKEMIA (2022)

Review Oncology

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

Rita Alaggio et al.

Summary: This article provides an overview of the upcoming 5th edition of the World Health Organization classification of lymphoid tumors, highlighting changes from the previous edition such as reorganization of entities, modification of nomenclature, revision of diagnostic criteria, deletion of entities, introduction of new entities, and inclusion of tumor-like lesions.

LEUKEMIA (2022)

Review Oncology

Germline and Somatic Defects in DDX41 and its Impact on Myeloid Neoplasms

Talha Badar et al.

Summary: DDX41 mutation is one of the most prevalent predisposition genes in adult myelodysplastic syndrome/acute myeloid leukemia. Most patients with DDX41 mutation do not have a family history of MDS/AML. DDX41 mutation leads to defects in cell growth and viability, likely related to the loss of tumor suppressor function. 70% of DDX41 mutations are associated with MDS/AML, with 25% of mutations being inherited mutations from germline cells. Recent studies suggest that a subgroup of patients with DDX41 mutation in myeloid neoplasms have a better clinical course and long-term survival.

CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2022)

Letter Hematology

Revision of RUNX1 variant curation rules

Simone Feurstein et al.

BLOOD ADVANCES (2022)

Letter Oncology

Classification of rare pediatric myeloid neoplasia-Quo vadis?

Charlotte M. Niemeyer et al.

LEUKEMIA (2022)

Review Oncology

Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies

Himachandana Atluri et al.

Summary: With the use of next generation sequencing (NGS), several genes have been identified that carry a risk of inheriting hematologic malignancies. Identification of individuals with hereditary hematologic malignancies (HHM) involves attention to family history, clinical features, and variant allele frequency on somatic NGS panels. Genetic counseling is critical for optimizing diagnostic testing and treatment strategies.

CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2022)

Article Biochemistry & Molecular Biology

Germline DNMT3A mutation in familial acute myeloid leukaemia

Courtney D. DiNardo et al.

Summary: A novel germline missense mutation DNMT3A p.P709S was identified in a mother and son pair with AML, showing dominant negative effects and global DNA hypomethylation. Somatic mutations in IDH2 and DNMT3A in AML patients indicate the crucial pathogenic interaction of these genes in leukemogenesis.

EPIGENETICS (2021)

Article Genetics & Heredity

Specifications of the ACMG/AMP variant interpretation guidelines for germline TP53 variants

Cristina Fortuno et al.

Summary: Germline pathogenic variants in TP53 are associated with Li-Fraumeni syndrome, a cancer predisposition disorder inherited in an autosomal dominant pattern. Intense cancer surveillance for individuals with these variants can reduce cancer-related mortality. Accurate classification of germline variants is crucial for ensuring appropriate cancer surveillance recommendations.

HUMAN MUTATION (2021)

Article Biochemistry & Molecular Biology

Germline POT1 Deregulation Can Predispose to Myeloid Malignancies in Childhood

Pia Michler et al.

Summary: This study identified a novel germline stop-gain variant in the shelterin complex gene POT1 in a child with acute myeloid leukemia, which resulted in increased DNA damage and chromosomal instabilities. The variant also led to telomeric elongation and highlighted the predisposition to myeloid malignancies in childhood caused by POT1 germline deficiency.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

Effective identification of cancer predisposition syndromes in children with cancer employing a questionnaire

Miriam Schwermer et al.

Summary: Using a one-page questionnaire significantly improves the diagnosis of children with CPS among those diagnosed with cancer, indicating a higher accuracy in identifying children with predisposition syndromes.

FAMILIAL CANCER (2021)

Article Biochemistry & Molecular Biology

Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes

Sushree S. Sahoo et al.

Summary: This study provides insights into the genetic determinants of disease progression and clinical outcomes in individuals with myelodysplastic syndromes, particularly those with SAMD9 and SAMD9L mutations. The findings suggest that somatic genetic rescue is common in SAMD9/9L(mut) MDS, showcasing the exceptional plasticity of hematopoiesis in children.

NATURE MEDICINE (2021)

Letter Oncology

Germline variants drive myelodysplastic syndrome in young adults

Simone Feurstein et al.

LEUKEMIA (2021)

Article Oncology

Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set An International Agency for Research on Cancer TP53 Database Analysis

Christian P. Kratz et al.

Summary: The study defines and classifies the phenotypic spectrum of Li-Fraumeni syndrome, providing insights into variant distribution and cancer characteristics in patients meeting different testing criteria. The new classification, Li-Fraumeni spectrum, may help understand phenotypic differences in cancer predisposition syndromes and serve as a model for further studies.

JAMA ONCOLOGY (2021)

Article Oncology

Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance

Carol Durno et al.

Summary: Surveillance and early cancer detection are associated with improved overall survival (OS) for individuals with CMMRD. In patients undergoing surveillance, GI and other solid tumors, as well as 75% of brain cancers, were detected asymptomatically. Adherence to the surveillance protocol resulted in significantly better survival outcomes, with a 4-year OS of 79% for patients undergoing full surveillance.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Hematology

Spectrum of hematological malignancies, clonal evolution and outcomes in 144 Mayo Clinic patients with germline predisposition syndromes

Emma St Martin et al.

Summary: Germline predisposition syndromes (GPS) are caused by constitutional abnormalities in tumor suppressive and homeostatic genes, leading to an increased risk of neoplasia in affected individuals. This study presented clinical and genomic data on 144 Mayo Clinic patients with GPS, revealing distinct patterns in different subtypes of GPS and the importance of comprehensive management approaches for patients with hematological neoplasms.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

Letter Hematology

A novel classification of hematologic conditions in patients with Fanconi anemia

Yvonne Lisa Behrens et al.

HAEMATOLOGICA (2021)

Article Multidisciplinary Sciences

The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants

Ana Rio-Machin et al.

NATURE COMMUNICATIONS (2020)

Article Biochemistry & Molecular Biology

Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes

Thierry Frebourg et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2020)

Article Hematology

Somatic genetic rescue in hematopoietic cells in GATA2 deficiency

Luiz Fernando B. Catto et al.

Article Genetics & Heredity

Contribution of de novo and mosaic TP53 mutations to Li-Fraumeni syndrome

Mariette Renaux-Petel et al.

JOURNAL OF MEDICAL GENETICS (2018)

Article Biochemistry & Molecular Biology

Pathogenic Germline Variants in 10,389 Adult Cancers

Kuan-lin Huang et al.

Review Hematology

Evaluating measurable residual disease in acute myeloid leukemia

Farhad Ravandi et al.

BLOOD ADVANCES (2018)

Article Medicine, Research & Experimental

Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans

Federica Buonocore et al.

JOURNAL OF CLINICAL INVESTIGATION (2017)

Article Hematology

DDX41-related myeloid neoplasia

Jaroslaw P. Maciejewski et al.

SEMINARS IN HEMATOLOGY (2017)

Review Clinical Neurology

Ataxia-telangiectasia: recommendations for multidisciplinary treatment

Nienke J. H. van Os et al.

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2017)

Article Oncology

Recommendations for Surveillance for Children with Leukemia-Predisposing Conditions

Christopher C. Porter et al.

CLINICAL CANCER RESEARCH (2017)

Article Oncology

Recommendations for Childhood Cancer Screening and Surveillance in DNA Repair Disorders

Michael F. Walsh et al.

CLINICAL CANCER RESEARCH (2017)

Article Genetics & Heredity

Recognition of genetic predisposition in pediatric cancer patients: An easy-to-use selection tool

Marjolijn C. J. Jongmans et al.

EUROPEAN JOURNAL OF MEDICAL GENETICS (2016)

Article Hematology

Genetic predisposition syndromes: When should they be considered in the work-up of MDS?

Daria V. Babushok et al.

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2015)

Review Hematology

How I treat juvenile myelomonocytic leukemia

Franco Locatelli et al.

Article Oncology

Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms

Chantana Polprasert et al.

CANCER CELL (2015)

Article Genetics & Heredity

Germ line ETV6 mutations in familial thrombocytopenia and hematologic malignancy

Michael Y. Zhang et al.

NATURE GENETICS (2015)

Article Multidisciplinary Sciences

Patterns and functional implications of rare germline variants across 12 cancer types

Charles Lu et al.

NATURE COMMUNICATIONS (2015)

Article Genetics & Heredity

The genomic landscape of hypodiploid acute lymphoblastic leukemia

Linda Holmfeldt et al.

NATURE GENETICS (2013)

Review Hematology

Recognizing familial myeloid leukemia in adults

Eric M. Nickels et al.

THERAPEUTIC ADVANCES IN HEMATOLOGY (2013)

Article Multidisciplinary Sciences

Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome

Yigal Dror et al.

ANNALS MEETING REPORTS (2011)

Letter Hematology

Managing individuals with propensity to myeloid malignancies due to germline RUNX1 deficiency

Tim Ripperger et al.

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)

Article Psychiatry

Psychosocial aspects of genetic testing

Linda D. Cameron et al.

CURRENT OPINION IN PSYCHIATRY (2009)